UTI Inc. (179900) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for UTI Inc. (179900:KRX), powered by AI.
- Current Price
- ₩17,540
- P/E Ratio
- -9.3
- Market Cap
- 347.1B
- Sector
- Technology
What is the UTI Inc. stock price forecast?
UTI Inc. is currently trading at ₩17,540. View real-time AI analysis on Alpha Lenz.
What is UTI Inc. insider trading activity?
View the latest insider trading data for UTI Inc. on Alpha Lenz.
What is UTI Inc.'s P/E ratio?
UTI Inc.'s P/E ratio is -9.3.
UTI Inc.
KRX · 179900“UTI Inc. trades at a P/E of -9.3 (undervalued) with modest ROE of -53.4%.”
Ask for details →Company Overview
UTI Inc. is a company involved in the manufacturing and supply of industrial components and tools. The primary function of UTI Inc. is to provide high-quality solutions that enhance manufacturing efficiency and precision in various industries. Focusing on sectors such as automotive, aerospace, and heavy machinery, the company plays a critical role in meeting the specialized needs of industrial operations worldwide. Notable features of UTI Inc. include a commitment to innovation and the development of cutting-edge technologies designed to improve productivity and performance. As a significant player in the industrial broad market, UTI Inc.'s impact is evidenced through its extensive distribution networks and partnerships, which facilitate widespread access to its products and services. Headquartered in a key industrial hub, UTI Inc. continues to drive progress and support the evolving needs of its global client base.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“UTI Inc. trades at a P/E of -9.3 (undervalued) with modest ROE of -53.4%.”
Ask for details →Frequently Asked Questions
UTI Inc. (ticker: 179900) is a company listed on KRX in the Technology sector (Electronic Components). It has approximately 130 employees. Market cap is $347.1B.
The current price is ₩17,540 with a P/E ratio of -9.28x and P/B of 5.31x.
ROE is -53.43% and operating margin is -241.89%. Annual revenue is $20.0B.